Skip to main content
Premium Trial:

Request an Annual Quote

In Print: Last Week's Microarray Papers of Note: Jan 21, 2014

Premium

Genome-wide copy number variation study and gene expression analysis identify ABI3BP as a susceptibility gene for Kashin-Beck disease.
Hum Genet. 2014 Jan 21. [Epub ahead of print]
Zhang F, et al.

The authors conducted the first genome-wide copy number variation study of KBD involving 2,743 Chinese Han adults. The study was first performed using Affymetrix Human SNP 6.0 Arrays. The identified copy number variations were then replicated in an independent Chinese Han sample containing 1,026 subjects.


Evaluation of homo- and hetero-functionally activated glass surfaces for optimized antibody arrays.
Anal Biochem. 2014 Jan 15. pii: S0003-2697(14)00014-1. [Epub ahead of print]
González-González M, et al.

The authors describe novel hetero-functionally activated glass surfaces favoring oriented antibody binding for improved performance in protein microarray applications. In a trial study, the technology enabled the concurrent detection of a set of membrane proteins under native conditions in a specific, selective, and semi-quantitative manner and in a single assay.


Echinacea purpurea (L.) Moench modulates human T-cell cytokine response.
Int Immunopharmacol. 2014 Jan 13. pii: S1567-5769(13)00508-0.
Fonseca F, et al.

The authors used Luminex bead-based immunoassays and flow cytometry to evaluate the composition of a neutral and weakly acidic water-soluble extract from Echinacea purpurea (L.) Moench, previously shown to modify the course of influenza infection in a mouse model, and to assess potential immunomodulatory effects on human T cells.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.